Comprehensive Insights on Amgen: Dividend and Recent Developments Before the Aug 22, 2025, Ex-Dividend Date

Amgen (AMGN) has announced its upcoming dividend details. The company has set an ex-dividend date of Aug 22, 2025, with an announcement made on Aug 1, 2025. Dividends are scheduled to be paid on Sep 12, 2025, at a rate of $2.38 per share. This amount is notably higher than the average of the last ten dividends per share, which stands at $1.274. The previous dividend was also issued at $2.38 per share, with the distribution type being a cash dividend.

Recently, Amgen has been in the spotlight for several significant events. As of late, the company reported a remarkable earnings beat, with earnings per share reaching $6.02, surpassing the estimated $5.28. This was accompanied by a 9.4% increase in revenue, showcasing Amgen's robust financial performance. Additionally, Amgen recently secured a legal victory that overturned a $50.3 million patent infringement verdict against Lindis Biotech. This development has positively influenced investor sentiment, as analysts indicated a potential boost in Amgen's stock performance. Over the past week, Amgen's strategic acquisition of Horizon Therapeutics has also been a focal point, further solidifying its position in the biotechnology sector. This acquisition, valued at approximately $27.8 billion, is one of Amgen's largest and is expected to enhance its therapeutic offerings, including treatments for rare diseases.

Amgen's financial health remains a critical area of analysis. The company's operating margin stands at 0.289, highlighting its efficient profit generation from core operations. However, the quick ratio of 0.817 suggests that Amgen may face challenges in covering short-term obligations if they were to come due simultaneously. The debt-to-equity ratio is notably high at 10.833, indicating a significant reliance on debt financing. These financial indicators are crucial for investors assessing the company's long-term viability and market competitiveness.

In conclusion, investors should note that Aug 22, 2025, is the ex-dividend date, marking the last opportunity to purchase Amgen's stock and be eligible for this dividend distribution. Any acquisitions made post this date will not qualify for the current dividend payout.